Christoph A Klein Selected Research

Dicyclohexylcarbodiimide (DCCD)

1/2018	The sentinel lymph node spread determines quantitatively melanoma seeding to non-sentinel lymph nodes and survival.
2/2014	Quantitative measurement of melanoma spread in sentinel lymph nodes and survival.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christoph A Klein Research Topics

Disease

36	Neoplasms (Cancer) 01/2022 - 04/2002
9	Neoplasm Metastasis (Metastasis) 11/2020 - 09/2008
9	Melanoma (Melanoma, Malignant) 02/2020 - 01/2004
7	Breast Neoplasms (Breast Cancer) 03/2021 - 09/2005
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 09/2008
4	Circulating Neoplastic Cells 11/2014 - 10/2013
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 02/2020
2	Prostatic Neoplasms (Prostate Cancer) 12/2014 - 04/2009
2	Disease Progression 01/2014 - 01/2005
2	Lung Neoplasms (Lung Cancer) 04/2012 - 02/2008
2	Carcinoma (Carcinomatosis) 01/2005 - 08/2002
1	Glioblastoma (Glioblastoma Multiforme) 03/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 02/2020
1	Esophageal Squamous Cell Carcinoma 01/2014
1	Fibrosarcoma 07/2009
1	Adenocarcinoma of Lung 09/2008
1	Adenocarcinoma 09/2008
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2008
1	Mycosis Fungoides 09/2008
1	Sezary Syndrome (Sezary Erythroderma) 09/2008
1	Esophageal Neoplasms (Esophageal Cancer) 05/2008
1	Chromosomal Instability (Chromosome Stability) 12/2004
1	Hematologic Neoplasms (Hematological Malignancy) 08/2002

Drug/Important Bio-Agent (IBA)

5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2005
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2008
4	Biomarkers (Surrogate Marker)IBA 02/2020 - 05/2008
4	AntigensIBA 04/2012 - 08/2002
3	Cell-Free Nucleic AcidsIBA 01/2022 - 02/2020
3	SuspensionsIBA 01/2019 - 07/2009
3	Messenger RNA (mRNA)IBA 04/2012 - 01/2004
3	RNA (Ribonucleic Acid)IBA 07/2005 - 08/2002
2	Epithelial Cell Adhesion MoleculeIBA 01/2022 - 12/2014
2	MART-1 AntigenIBA 01/2019 - 08/2005
2	LigandsIBA 04/2018 - 08/2002
2	Dicyclohexylcarbodiimide (DCCD)IBA 01/2018 - 02/2014
2	Keratin-19 (Keratin 19)IBA 03/2010 - 07/2005
2	Keratins (Keratin)IBA 04/2009 - 09/2005
1	Tumor Biomarkers (Tumor Markers)IBA 01/2022
1	cyclohexane- 1,2,4- tris(methylenesulfonate) (CTMS)IBA 03/2021
1	Citric Acid (Citrate)FDA LinkGeneric 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	gluconic acid (gluconate)FDA LinkGeneric 01/2021
1	Interleukin-6 (Interleukin 6)IBA 10/2020
1	Nucleic AcidsIBA 02/2020
1	UbiquitinIBA 04/2018
1	68Ga-pentixaforIBA 04/2018
1	Therapeutic UsesIBA 01/2018
1	Progesterone FDA LinkGeneric 12/2016
1	Cyclin D1IBA 10/2014
1	antineoplaston A10 (A 10)IBA 02/2014
1	IntegrinsIBA 01/2014
1	Thymidine KinaseIBA 03/2011
1	CollagenIBA 07/2009
1	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 07/2009
1	Matrix Metalloproteinases (MMPs)IBA 09/2008
1	Metalloproteases (Metalloproteinases)IBA 09/2008
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 09/2008
1	AntibodiesIBA 08/2005
1	Biological ProductsIBA 12/2004
1	Chondroitin Sulfate ProteoglycansIBA 01/2004
1	Monoclonal AntibodiesIBA 01/2004
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2004
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 08/2002
1	Minor Histocompatibility AntigensIBA 08/2002
1	Peptides (Polypeptides)IBA 08/2002

Therapy/Procedure

19	Therapeutics 11/2020 - 04/2002
2	Lymph Node Excision (Lymph Node Dissection) 01/2018 - 07/2005
2	Immunotherapy 03/2010 - 08/2002
1	Drug Therapy (Chemotherapy) 01/2014
1	Life Support Care 03/2011
1	Heterologous Transplantation (Xenotransplantation) 02/2009
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2008
1	Neoadjuvant Therapy 07/2005
1	Stem Cell Transplantation 08/2002